The COVID-19 pandemic has driven rapid, widespread adoption of telemedicine. The distribution of clinicians, long travel distances, and disability all limit access to care, especially for persons with Parkinson’s disease. Telemedicine is not a panacea for all of these challenges but does offer advantages. These advantages can be summarized as the 5 C’s: accessible care, increased convenience, enhanced comfort, greater confidentiality to patients and families, and now reduced risk of contagion. Telemedicine also has its limitations, including the inability to perform parts of the physical examination and inequitable access to the Internet and related technologies. Future models will deliver care to patients from a diverse set of specialties. These will include mental health specialists, physiotherapists, neurosurgeons, speech-language therapists, dieticians, social workers, and exercise coaches. Along with these new care models, digital therapeutics, defined as treatments delivered through software programs, are emerging. Telemedicine is now being introduced as a bridge to restart clinical trials and will increasingly become a normal part of future research studies. From this pandemic will be a wealth of new telemedicine approaches which will fundamentally change and improve care as well as research for individuals with Parkinson’s disease.

中文翻译：

---

护理，便利性，舒适性，保密性和传染性：将塑造远程医疗未来的5C。

COVID-19大流行推动了远程医疗的迅速广泛采用。临床医生的分布，长途旅行和残疾都限制了获得护理的机会，特别是对于患有帕金森氏病的人。远程医疗并不是应对所有这些挑战的灵丹妙药，但确实具有优势。这些优势可以概括为5 C：可得到的护理，增加的便利性，增强的舒适性，对患者和家庭的更高保密性以及现在降低了传染风险。远程医疗也有其局限性，包括无法进行部分身体检查以及对互联网和相关技术的不平等访问。未来的模式将为各种专业领域的患者提供护理。这些人员将包括心理健康专家，物理治疗师，神经外科医生，言语治疗师，营养师，社会工作者和运动教练。随着这些新的护理模型的出现，数字疗法被定义为通过软件程序提供的疗法。如今，远程医疗正被引入作为重新启动临床试验的桥梁，并将逐渐成为未来研究的正常部分。这种大流行将带来大量新的远程医疗方法，这些方法将从根本上改变和改善对帕金森氏病患者的护理以及研究。